Idéal Investisseur Galteron Galteron
Français English
CAC 40 : Market closed
8 216,78 pts
-1.62%


Last updated : 17/11/2026 - 17h37
🏠 Home   ➤    Stock news

Abivax shares drop 27% over three months and slip to the tail of the SBF 120

The Paris-based biotech specialising in inflammatory diseases is in negative territory mid-morning, in a Paris market trending lower. The move extends a difficult quarter and leaves the stock far from its long-term reference levels, while short positions remain in place.


Abivax shares drop 27% over three months and slip to the tail of the SBF 120

A stock below its three moving averages after a quarter at -27%

Abivax shares fell 2.8% to €74.75 during the session, while the CAC 40 declined 1.06%, and the stock ranks among the largest decliners in the SBF 120. It has lost 27.2% over three months and remains below its three moving averages: the MM20 is at €79.38, 5.8% above the price, and the MM200 at €97.79.

The price has fallen back below €76.05, the lowest level of the last 30 sessions, which has been broken to the downside and has become resistance. Analyst opinions are not included in this item, which is limited to price levels.

Abivax is a single company listed on two exchanges: the ordinary share in Paris, eligible for the PEA, and the ADS on the Nasdaq, which represents the same security on a one-for-one ratio. Both lines quote the same price in real time.

Five funds hold 5.59% of the capital in net short position

According to the declarations reviewed, five funds together hold a net short position of 5.59% of the capital, up 0.24 points over thirty days. This level is high: it shows that institutional investors remain positioned against the stock or are seeking to hedge an exposure.

The increase over one month remains moderate and does not, on its own, reflect a massive lack of confidence, but the point deserves to be monitored alongside the price.

The stock had already fallen back below €76.05 on Monday. The session is taking place in a context of heightened volatility, with the VIX gaining nearly 23%. The €76.05 level is now the nearest resistance, and the €63.10 support is the next threshold below the price.

Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning ✓ Euronext data ✓ AI-powered analysis


Sector Pharmacie et biotechnologies › Biotechnologies


Context

Period
  • Period: S1 2026
Key reported figures
  • Net income: -165,9 millions d'euros

The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.

Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.

Advertisement
Every morning
Technical market signals,
before the opening bell.
CAC 40 · SBF 120 · Signals · Analysts
🤖
Today's edition — pre-market
CAC 40
7 702
-0,87%
SBF 120
5 827
-0,87%
📈 Bullish signals
+5,2%
+1,8%
+0,9%
📉 Bearish signals
-14%
-5,7%
🔄 Analyst opinions
▲ 35 €
▼ 80 €
Sign up to see everything →
Before 9 AM every morning
Euronext data
AI-powered analysis





BOURSE · Chaque matin
La synthèse bourse,
avant l'ouverture.
Notre moteur analyse chaque nuit le CAC 40 et le SBF 120. Ce qui mérite attention remonte directement dans votre boîte mail. Gratuit.
✓ Avant 9h00 ✓ 1000+ inscrits ✓ 100% gratuit
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours sur les valeurs Euronext, chaque matin avant 9h.
tendance · 6 séances
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours